TickerFactsScreenerDevelopers

Edwards Lifesciences Corp (EW) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2008: $419.60M2009: $399.10M2010: $408.30M2011: $489.80M2012: $491.00M2013: $516.60M2014: $625.60M2015: $617.20M2016: $797.40M2017: $875.30M2018: $939.40M2019: $1.11B2020: $1.08B2021: $1.25B2022: $723.70M2023: $978.40M2024: $1.12B2025: $1.33B$1.33B
2008Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$1.33B+19.4%
2024$1.12B+14.2%
2023$978.40M+35.2%
2022$723.70M-42.1%
2021$1.25B+15.6%
2020$1.08B-3.0%
2019$1.11B+18.6%
2018$939.40M+7.3%
2017$875.30M+9.8%
2016$797.40M+29.2%
2015$617.20M-1.3%
2014$625.60M+21.1%
2013$516.60M+5.2%
2012$491.00M+0.2%
2011$489.80M+20.0%
2010$408.30M+2.3%
2009$399.10M-4.9%
2008$419.60M—